• Open-Platform DLP Enables High-Throughput Hydrogel Printing

  2026-05-07

  This study introduces a low-cost, open-platform digital light printer (OP-DLP) for precise hydrogel printing and localized light-activation in a 96-well format. The platform’s flexibility and reproducibility address major limitations in high-throughput biomaterials research, with implications for cell-based assays and integrin-targeting workflows.

• Applied Innovations with Prostaglandin E2 in Inflammation Re

  2026-05-06

  Prostaglandin E2 (PGE2) unlocks advanced control of immune and inflammation pathways, enabling high-precision experimental models across GI, cardiovascular, and reproductive systems. This article provides actionable protocol enhancements, real-world troubleshooting, and evidence-backed insights for maximizing the impact of APExBIO's PGE2 in applied research.

• Pharmacogenomics of Chloroquine and Hydroxychloroquine: Clin

  2026-05-06

  This review systematically synthesizes current pharmacogenomic evidence for chloroquine and hydroxychloroquine, focusing on how CYP450 genetic variants influence drug safety and efficacy. The findings underscore the importance of personalized medicine strategies and highlight key risks for diverse patient populations.

• Therapy Sequencing in Waldenström Macroglobulinemia: Role of

  2026-05-05

  This review analyzes the recent evidence on optimizing therapy sequencing in Waldenström macroglobulinemia (WM), focusing on the clinical and genomic factors—particularly MYD88 and CXCR4 mutations—that inform treatment selection. Insights into the emerging role of CXCR4 antagonists support experimental approaches for refractory or genetically complex WM.

• Intestinal TM6SF2 Preserves Gut–Liver Axis to Prevent MASH P

  2026-05-05

  This study demonstrates that intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and regulating gut microbiota. Mechanistic investigation revealed that TM6SF2 deficiency in intestinal epithelial cells leads to microbial dysbiosis, increased free fatty acid secretion, lysophosphatidic acid accumulation, and hepatic inflammation, highlighting new intervention points for MASH.

• Elobixibat Hydrate: Optimizing IBAT Inhibitor Workflows in R

  2026-05-04

  Elobixibat hydrate stands out as a selective ileal bile acid transporter inhibitor, enabling advanced modeling of gastrointestinal and metabolic pathways. This article delivers actionable experimental protocols, troubleshooting insights, and translational comparisons that empower researchers to maximize reproducibility and precision in studies of chronic idiopathic constipation and type 2 diabetes.

• Thiothixene: Bridging Antipsychotic Action and Macrophage Ef

  2026-05-04

  This thought-leadership article explores how thiothixene, a well-established typical antipsychotic agent, is redefining translational research by modulating both dopamine signaling and macrophage efferocytosis. Integrating mechanistic insights, recent peer-reviewed findings, and protocol guidance, we provide strategic direction for researchers seeking to leverage thiothixene’s dual action in neuropsychiatric and immunological contexts. The piece also situates APExBIO’s thiothixene product within this evolving landscape, citing rigorous evidence and scenario-based recommendations.

• N6-Methyl-dATP: Advancing DNA Replication Fidelity Studies

  2026-05-03

  N6-Methyl-dATP empowers researchers to dissect the role of methylation in DNA replication fidelity and genomic stability, with streamlined protocols for epigenetic and translational workflows. This guide details experimental strategies, troubleshooting, and optimization tips for leveraging this unique nucleotide analog in both cancer and antiviral research.

• Transcription Termination Limits DNA Damage After WEE1 Inhib

  2026-05-02

  This study uncovers how efficient transcription termination safeguards genome integrity by limiting DNA damage following WEE1 kinase inhibition in cancer cells. The findings clarify the molecular interplay between replication stress and transcriptional regulation, informing new strategies for targeting transcription-replication conflicts in oncology.

• AEBSF.HCl in Necroptosis & Amyloid Research: Applied Insight

  2026-05-02

  AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) offers precision serine protease inhibition, enabling rigorous control in necroptosis and amyloid precursor protein assays. This guide delivers practical workflows, troubleshooting strategies, and evidence-based parameters to maximize reliability in cell death and neurodegeneration studies.

• Mavorixafor Hydrochloride: Next-Generation CXCR4 Antagonist

  2026-05-01

  Explore the advanced pharmacology of Mavorixafor hydrochloride, a potent CXCR4 antagonist, with unique mechanistic insights informed by seminal protoplast research. Delve into experimental design, refined assay strategies, and emerging anti-HIV applications.

• Scutellarin Modulates Cathepsin D to Restore Endothelial Aut

  2026-04-30

  This study demonstrates that scutellarin protects endothelial cells from ischemia/reperfusion injury by upregulating cathepsin D, thereby restoring autophagy-lysosomal function. Inhibition or knockdown of cathepsin D abrogates this protective effect, highlighting a critical pathway for potential therapeutic intervention.

• Mavorixafor Hydrochloride: CXCR4 Antagonist for Immune Modul

  2026-04-30

  Mavorixafor hydrochloride (AMD-070 hydrochloride) is a potent, orally bioavailable CXCR4 antagonist that disrupts CXCR4/CXCL12 signaling. This compound increases neutrophil and lymphocyte counts and reduces infection rates in CXCR4 mutation-associated disorders, with a favorable safety profile. It is manufactured by APExBIO for research use.

• Tetrahydromagnolol: Advancing CB2 Agonism in Translational R

  2026-04-29

  Explore how tetrahydromagnolol, a potent peripheral CB2 receptor agonist, reshapes cannabinoid receptor research and translational strategies. This thought-leadership piece integrates mechanistic insights, experimental considerations, and strategic guidance for targeting inflammation, analgesia, and metastatic mechanisms. Building on recent GPCR research, it highlights tetrahydromagnolol's unique value for anti-inflammatory and analgesic mechanism studies, with a special focus on translational relevance and workflow optimization.

• Methyl-β-cyclodextrin: Practical Parameters for Membrane Res

  2026-04-29

  Methyl-β-cyclodextrin (SKU C6939) is a high-purity reagent designed for selective extraction of cholesterol and certain lipids from cellular membranes, supporting studies of membrane fluidity, lipid raft organization, and cholesterol-dependent signaling. It is strictly intended for research workflows and should not be used in diagnostic or clinical settings due to usage and storage limitations.

451 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page